FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20479411000001109: Doxorubicin hydrochloride liposomal pegylated (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68938101000001118 Doxorubicin hydrochloride liposomal pegylated (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68938201000001113 Doxorubicin hydrochloride liposomal pegylated en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxorubicin hydrochloride liposomal pegylated Is a Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 50mg/25ml solution for infusion vials Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 50mg/25ml solution for infusion vials 1 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) 1 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) 1 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) 2 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials 2 vial Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has specific active ingredient True Doxorubicin hydrochloride liposomal pegylated Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start